Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The investigators aim is to investigate whether adjuvant Pentoxifylline , IgM enriched IVIG
or Pentoxifylline plus IgM-enriched IVIG reduced mortality from Neonatal sepsis.
Phase:
Phase 4
Details
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital